These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 3037881)
1. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease. Kawasaki H; Uemasu J; Maeda N; Hirayama C; Kobayashi T; Sakurai H Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system. Colantonio D; Casale R; Pasqualetti P Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427 [TBL] [Abstract][Full Text] [Related]
3. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457 [TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis. Burghardt W; Wernze H; Diehl KL Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055 [TBL] [Abstract][Full Text] [Related]
5. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising. Burghardt W; Müller R; Diehl KL; Wernze H Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163 [TBL] [Abstract][Full Text] [Related]
6. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide. Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696 [TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide, arginine vasopressin, aldosterone and plasma renin activity in carbon tetrachloride-induced cirrhosis in rats. Elias AN; Vaziri ND; Domurat ES; Pandian MR; Ansari MA; Yazdani M J Pharmacol Exp Ther; 1990 Jan; 252(1):438-41. PubMed ID: 2137178 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of plasma endothelin-1 in patients with chronic liver disease. Matsumoto H; Uemasu J; Kitano M; Kawasaki H Dig Dis Sci; 1994 Dec; 39(12):2665-70. PubMed ID: 7995194 [TBL] [Abstract][Full Text] [Related]
9. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide. Trevisani F; Colantoni A; Sica G; Gasbarrini A; D'Intino PE; De Notariis S; De Jaso R; Barbieri A; Morselli A; Gasbarrini G Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404 [TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites. Bonkovsky HL; Hartle DK; Mellen BG; Kutner M; Galambos JT Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574 [TBL] [Abstract][Full Text] [Related]
11. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites. Jiménez W; Gutkowska J; Ginés P; Arroyo V; Rivera F; Rodés J Hepatology; 1991 Oct; 14(4 Pt 1):601-7. PubMed ID: 1833302 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200 [TBL] [Abstract][Full Text] [Related]
13. The atrial natriuretic peptide-renin-aldosterone system in hepatorenal syndrome. Pasqualetti P; Casale R Riv Eur Sci Med Farmacol; 1996; 18(4):137-41. PubMed ID: 9177611 [TBL] [Abstract][Full Text] [Related]
14. Increased plasma levels of adrenomedullin in patients with heart failure. Nishikimi T; Saito Y; Kitamura K; Ishimitsu T; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H J Am Coll Cardiol; 1995 Nov; 26(6):1424-31. PubMed ID: 7594065 [TBL] [Abstract][Full Text] [Related]
15. Fluid homeostasis after heart transplantation: the role of cardiac denervation. Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982 [TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide in patients with decompensated hepatic cirrhosis. Tulassay T; Tulassay Z; Rascher W Gastroenterol J; 1990; 50(3):140-3. PubMed ID: 2149634 [TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of atrial natriuretic peptide in human plasma: application to studies of volume and blood pressure homeostasis. Horký K; Srámková J; Tesar V; Lachmanová J; Widimský J Physiol Bohemoslov; 1988; 37(4):299-305. PubMed ID: 2973615 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum and urinary neopterin levels in patients with various liver diseases. Daito K; Suou T; Kawasaki H Am J Gastroenterol; 1992 Apr; 87(4):471-6. PubMed ID: 1313206 [TBL] [Abstract][Full Text] [Related]
19. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume. Akriviadis EA; Ervin MG; Cominelli F; Fisher DA; Reynolds TB Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977 [TBL] [Abstract][Full Text] [Related]
20. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Wong F; Siu S; Liu P; Blendis LM Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]